{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:21:19Z","timestamp":1777879279117,"version":"3.51.4"},"reference-count":63,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"INOMED, co-funded by the European Union","award":["reg.No.CZ.02.1.01\/0.0\/0.0\/18_069\/0010046"],"award-info":[{"award-number":["reg.No.CZ.02.1.01\/0.0\/0.0\/18_069\/0010046"]}]},{"name":"EU COST Action","award":["EU COST Action IS1402"],"award-info":[{"award-number":["EU COST Action IS1402"]}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["EUROAGEISM, No 764632, H2020-MSCA-ITN (2017-2021)"],"award-info":[{"award-number":["EUROAGEISM, No 764632, H2020-MSCA-ITN (2017-2021)"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Drug Safety"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The European Union (EU)(7)-PIM (potentially inappropriate medication) list presents the most comprehensive and up-to-date tool for evaluation of PIM prescribing in Europe; however, several country-specific studies have documented lower specificity of this list on pharmaceutical markets of some countries. The aim of our study was to describe approval rates and marketing of PIMs stated by EU(7)-PIM criteria in six EU countries [in comparison with the American Geriatric Society (AGS) Beers 2015 criteria].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Research teams of six EU countries (Czech Republic, Spain, Portugal, Serbia, Hungary and Turkey) participated in this study conducted by WG1b EU COST Action IS1402 group in the period October 2015\u2013November 2018. Data on approval rates of PIMs and their availability on pharmaceutical markets have been obtained from databases of national drug-regulatory institutes and up-to-date drug compendia. The EU(7)-PIM list and AGS Beers 2015 Criteria (Section 1) were applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>PIMs from EU(7)-PIM list were approved for clinical use more often than those from the AGS Beers 2015 criteria (Section 1). Approval rates for EU(7)-PIMs ranged from 42.8% in Serbia to 71.4% in Spain (for AGS criteria only from 36.4% to 65.1%, respectively). Higher percentages of approved PIMs were documented in Spain (71.4%), Portugal (67.1%) and Turkey (67.5%), lower in Hungary (55.5%), Czech Republic (50.2%) and Serbia (42.8%). The majority of approved PIMs were also currently marketed in all countries except in Turkey (19.8\u201321.7% not marketed PIMs) and less than 20% of PIMs were available as over-the-counter medications (except in Turkey, 46.4\u201348.1%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The EU(7)-PIM list was created for utilization in European studies; however, applicability of this list is still limited in some countries, particularly in Eastern and Central Europe. The EU project EUROAGEISM H2020 (2017\u20132021) that focuses on PIM prescribing and regulatory measures in Central and Eastern European countries must consider these limits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/2042098619854014","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T03:21:42Z","timestamp":1561346502000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Applicability of EU(7)-PIM criteria in cross-national studies in European countries"],"prefix":"10.1177","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-9690","authenticated-orcid":false,"given":"Daniela","family":"Fialov\u00e1","sequence":"first","affiliation":[{"name":"Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kr\u00e1lov\u00e9, Charles University, Heyrovsk\u00e9ho 1203, Hradec Kr\u00e1lov\u00e9 500 05, Czech Republic"},{"name":"Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Prague, Czech Republic"}]},{"given":"Jovana","family":"Brki\u0107","sequence":"additional","affiliation":[{"name":"Department of Social and Clinical Pharmacy, Charles University, Czech Republic"}]},{"given":"Blanca","family":"Laffon","sequence":"additional","affiliation":[{"name":"DICOMOSA Group, Department of Psychology, Universidade da Coru\u00f1a, A Coru\u00f1a, Spain"}]},{"given":"Jindra","family":"Reissigov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Statistical Modeling, The Czech Academy of Sciences, Prague, Czech Republic"}]},{"given":"Silvia","family":"Gre\u0161\u00e1kov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Social and Clinical Pharmacy, Charles University, Czech Republic"}]},{"given":"Soner","family":"Dogan","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Yeditepe University, Istanbul, Turkey"}]},{"given":"Peter","family":"Doro","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of Szeged, Szeged, Hungary"}]},{"given":"Ljiljana","family":"Tasi\u0107","sequence":"additional","affiliation":[{"name":"Department of Social Pharmacy and Pharmaceutical Legislation, University of Belgrade, Belgrade, Serbia"}]},{"given":"Valentina","family":"Marinkovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Social Pharmacy and Pharmaceutical Legislation, University of Belgrade, Belgrade, Serbia"}]},{"given":"Vanessa","family":"Valdiglesias","sequence":"additional","affiliation":[{"name":"DICOMOSA Group, Department of Psychology, Universidade da Coru\u00f1a, A Coru\u00f1a, Spain"}]},{"given":"Solange","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Environmental Health, Portuguese National Institute of Health, Porto, Portugal"},{"name":"EPIUnit, University of Porto, Porto, Portugal"}]},{"given":"Jan","family":"Kost\u0159iba","sequence":"additional","affiliation":[{"name":"Department of Social and Clinical Pharmacy, Charles University, Czech Republic"}]}],"member":"179","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"bibr1-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12732"},{"key":"bibr2-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2015-000864"},{"key":"bibr3-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1991.00400090107019"},{"key":"bibr4-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13702"},{"key":"bibr5-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15767"},{"key":"bibr6-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afu145"},{"key":"bibr7-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1860-9"},{"key":"bibr8-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0324-2"},{"key":"bibr9-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1080\/02813430902992215"},{"key":"bibr10-2042098619854014","doi-asserted-by":"publisher","DOI":"10.3109\/02813432.2015.1041833"},{"key":"bibr11-2042098619854014","first-page":"543","volume":"107","author":"Holt S","year":"2010","journal-title":"Dtsch Arztebl Int"},{"key":"bibr12-2042098619854014","first-page":"385","volume":"156","author":"McLeod PJ","year":"1997","journal-title":"CMAJ"},{"key":"bibr13-2042098619854014","first-page":"4","author":"Rancourt C","year":"2004","journal-title":"BMC Geriatr"},{"key":"bibr14-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13884"},{"key":"bibr15-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014552821"},{"key":"bibr16-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afu029"},{"key":"bibr17-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0321-5"},{"key":"bibr18-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014548568"},{"key":"bibr19-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glw140"},{"key":"bibr20-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2016.06.011"},{"key":"bibr21-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1954-4"},{"key":"bibr22-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14077"},{"key":"bibr23-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008656"},{"key":"bibr24-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.11.1348"},{"key":"bibr25-2042098619854014","unstructured":"European Medicines Agency. The European regulatory system for medicines and the European Medicines Agency. A consistent approach to medicines regulation across the European Union. EMA\/437313\/2014. European Medicines Agency, http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Brochure\/2014\/08\/WC500171674.pdf (2019, accessed 14 March)."},{"key":"bibr26-2042098619854014","unstructured":"European Commission. Regulation (EC) no. 726\/2004 of the European parliament and of the council laying down community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-1\/reg_2004_726\/reg_2004_726_en.pdf (2018, accessed 11 March)."},{"key":"bibr27-2042098619854014","unstructured":"European Medicines Agency. Human medicines research and development support. European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure. EMA\/339324\/2007, http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Regulatory_and_procedural_guideline\/2009\/10\/WC500004069.pdf (2019, accessed 11 March)."},{"key":"bibr28-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1947-3"},{"key":"bibr29-2042098619854014","unstructured":"COST Action IS1402 on Ageism. COST Action IS1402 on Ageism - home page, http:\/\/notoageism.com\/,(accessed 10 July 2018)."},{"key":"bibr30-2042098619854014","unstructured":"EuroAgeism Horizon 2020 Project. EuroAgeism Horizon 2020 project - home page, http:\/\/euroageism.eu\/ (accessed 20 November 2018)."},{"key":"bibr31-2042098619854014","unstructured":"GEMA\u015e Genel M\u00fchendislik Mekanik San. ve Tic. A\u015e RxMediaPharma, http:\/\/eczanet.com\/kurulum.html (accessed 20 November 2018)."},{"key":"bibr32-2042098619854014","unstructured":"General Council of Official Associations of Pharmacists. Bot PLUS WEB, https:\/\/botplusweb.portalfarma.com\/ (accessed 20 November 2018)."},{"key":"bibr33-2042098619854014","unstructured":"Medicines Catalog,\n                      Madrid, Spain, 2018. General Council of Official Associations of Pharmacists."},{"key":"bibr34-2042098619854014","unstructured":"INFARMED: National Authority of Medicines and Health Products IP. INFARMED: National Authority of Medicines and Health Products IP, home page, http:\/\/www.infarmed.pt\/web\/infarmed-en\/ (accessed 1 December 2018)."},{"key":"bibr35-2042098619854014","unstructured":"INFARMED - National Authority of Medicines and Health Products IP. Infomed - medicines database, http:\/\/app7.infarmed.pt\/infomed\/ (accessed 29 November 2018)."},{"key":"bibr36-2042098619854014","unstructured":"Medicines and Medical Devices Agency of Serbia. Search - human medicines, https:\/\/www.alims.gov.rs\/latin\/lekovi\/pretrazivanje-humanih-lekova\/ (accessed 1 December 2018)."},{"key":"bibr37-2042098619854014","unstructured":"Medicines and Medical Devices Agency of Serbia. National Medicines Registry - NRL 2016 Belgrade, Serbia, 2016."},{"key":"bibr38-2042098619854014","unstructured":"National Health Insurance Fund of Hungary. National Health Insurance Fund of Hungary - home page, http:\/\/neak.gov.hu\/ (accessed 25 November 2018)."},{"key":"bibr39-2042098619854014","unstructured":"National Health Insurance Fund of the Republic of Serbia. National Health Insurance Fund of the Republic of Serbia, home page, http:\/\/www.eng.rfzo.rs\/index.php\/aboutus(accessed 27 November 2018)."},{"key":"bibr40-2042098619854014","unstructured":"National Institute of Pharmacy and Nutrition. National Institute of Pharmacy and Nutrition - home page, http:\/\/ogyei.gov.hu (accessed 29 November 2018)."},{"key":"bibr41-2042098619854014","unstructured":"Spanish Agency of Medicines and Sanitary Products. Center of online information on medicines, https:\/\/cima.aemps.es\/cima\/publico\/home.html (accessed 27 November 2018)."},{"key":"bibr42-2042098619854014","unstructured":"State Institute for Drug Control. State Institute for Drug Control, home page, http:\/\/www.sukl.eu\/ (accessed 25 November 2018)."},{"key":"bibr43-2042098619854014","unstructured":"Turkish Medicines and Medical Devices Agency. Turkish Medicines and Medical Devices Agency (TMMDA), home page, https:\/\/www.titck.gov.tr\/ (accessed November 27 2018)."},{"key":"bibr44-2042098619854014","unstructured":"European Statistical System. Census data, home page, https:\/\/ec.europa.eu\/CensusHub2\/query.do?step=selectHyperCube&countrycode=en&clearSession=true (accessed 12 December 2018)."},{"key":"bibr45-2042098619854014","unstructured":"Statistical Office of the Republic of Serbia. Age and sex data by settlements, home page, http:\/\/www.stat.gov.rs\/en-US\/oblasti\/popis\/popis-2011\/popisni-podaci-eksel-tabele (accessed 12 December 2018)."},{"key":"bibr46-2042098619854014","unstructured":"Turkish Statistical Institute. Population censuses, home page. http:\/\/www.turkstat.gov.tr\/VeriBilgi.do?alt_id=1047 (accessed 12 December 2018)."},{"key":"bibr47-2042098619854014","unstructured":"Cerveny R, Topinkova E. Recommended diagnostic and therapeutic procedures for general practitioners \u2013 Geriatrics. http:\/\/www.svl.cz\/files\/files\/Doporucene-postupy-od-2013\/DP-Geriatrie-2014.pdf (accessed 07 December 2018)."},{"key":"bibr48-2042098619854014","unstructured":"Health Office, Madrid Autonomous Community Government. Potentially inappropriate medications in older people, http:\/\/www.madrid.org\/cs\/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobheadervalue1=filename%3DMPI+Presentaci%C3%B3n.pdf&blobkey=id&blobtable=MungoBlobs&blobwhere=1352861934227&ssbinary=true (accessed 9 December 2018)."},{"key":"bibr49-2042098619854014","unstructured":"Health and Consumer Department, Basque Country Autonomous Community Government. Pharmacotherapeutic guide for geriatric patients, http:\/\/www.osakidetza.euskadi.eus\/contenidos\/informacion\/publicaciones_informes_estudio\/es_pub\/adjuntos\/guia_pacientes_geriatricos.pdf (accessed 9 December 2018)."},{"key":"bibr50-2042098619854014","unstructured":"Turkish Medicines and Medical Devices Agency. Rational drug use in older patients, http:\/\/www.akilciilac.gov.tr\/?page_id=767 (accessed 1 December 2018)."},{"key":"bibr51-2042098619854014","unstructured":"Ministry of Health, Turkish Medicines and Medical Devices Agency. Report from the workshop: current problems and solutions for drug use in elderly, http:\/\/www.akilciilac.gov.tr\/wp-content\/uploads\/2015\/12\/Geriatri-Rapor-Son.pdf (accessed 1 December 2018)."},{"key":"bibr52-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2534-1"},{"key":"bibr53-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12494"},{"key":"bibr54-2042098619854014","doi-asserted-by":"publisher","DOI":"10.31086\/tjgeri.2018137962"},{"key":"bibr55-2042098619854014","first-page":"296","volume":"20","author":"\u00d6zt\u00fcrk GZ","year":"2017","journal-title":"Turk Geriatri Dergisi"},{"key":"bibr56-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.13073"},{"key":"bibr57-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13505"},{"key":"bibr58-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2246-y"},{"key":"bibr59-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13701"},{"key":"bibr60-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.13331"},{"key":"bibr61-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1061-0"},{"key":"bibr62-2042098619854014","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-017-0426-6"},{"key":"bibr63-2042098619854014","first-page":"9","author":"Kova\u010devi\u0107 SV","year":"2014","journal-title":"PLoS One"}],"container-title":["Therapeutic Advances in Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2042098619854014","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2042098619854014","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2042098619854014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:39:13Z","timestamp":1777592353000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2042098619854014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":63,"alternative-id":["10.1177\/2042098619854014"],"URL":"https:\/\/doi.org\/10.1177\/2042098619854014","relation":{},"ISSN":["2042-0986","2042-0994"],"issn-type":[{"value":"2042-0986","type":"print"},{"value":"2042-0994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"article-number":"2042098619854014"}}